top stories

Wet AMD biotech stock soars over 200% as lead as­set match­es Re­gen­eron’s Eylea in PhII test

1 hour ago
R&D

Up­dat­ed: Roche buys obe­si­ty and di­a­betes biotech Car­mot Ther­a­peu­tics in $2.7B merg­er deal

7 hours ago
Deals

Ab­bisko signs $70M up­front deal with Mer­ck KGaA for PhI­II can­cer drug

2 hours ago
Deals
China

House com­mit­tee in­ves­ti­gates FDA’s han­dling of com­mon nasal de­con­ges­tant as ef­fi­ca­cy ques­tions loom

40 minutes ago
Pharma
FDA+

Latest

Ideaya part­ners with Gilead; Lil­ly ex­tends of­fer for Point; The­seus lets go of CEO, CMO

1 hour ago
News Briefing

At­se­na touts one-year da­ta for con­gen­i­tal eye dis­ease ther­a­py as it seeks part­ner for piv­otal study

1 hour ago
R&D
Cell/Gene Tx

WuXi Bi­o­log­ics’ stock slides by 24% as man­u­fac­tur­ing busi­ness slows amid biotech down­turn

5 hours ago
Manufacturing

No­var­tis un­veils new brand iden­ti­ty af­ter San­doz spin­off

5 hours ago
Pharma
Marketing

UCSF sci­en­tists aim to un­rav­el autism with brain organoids and AI

5 hours ago
R&D
AI

Seis­mic rais­es $121M to en­ter im­munol­o­gy space spot­light­ed by ar­genx, Im­muno­vant and oth­ers

5 hours ago
Financing
R&D
see latest stream
People

Or­na Ther­a­peu­tics trims staff in ‘de­fen­sive re­duc­tion’ de­spite large fi­nanc­ing hauls

4 days ago

Gilead­'s cell ther­a­py busi­ness Kite cuts 7% of work­force

4 days ago

Gen­er­a­tion Bio to lay off 68 em­ploy­ees in a dif­fi­cult year for non-vi­ral gene ther­a­py biotechs

5 days ago
Financing

Ex­clu­sive: San Diego biotech rais­es $11.7M to use cells as tar­get­ed de­liv­ery ves­sels for ge­net­ic med­i­cines

3 days ago

ARCH-al­lied AN Ven­ture Part­ners rais­es $200M to build biotechs out of re­search from Japan

3 days ago

Small transpa­cif­ic team led by Lil­ly, Ever­est vet turns to com­pu­ta­tion­al tools for next wave of pep­tide drug ...

3 days ago
Startups

Neu­ro start­up stock craters af­ter PhI­II study marred with ‘sig­nif­i­cant de­vi­a­tion’ from tri­al pro­to­col

5 days ago

Flag­ship opens hub, plants roots in the UK as gov­ern­ment aims to boost life sci­ence ecosys­tem

6 days ago

Flag­ship launch­es first UK-based start­up to un­cov­er genes that make cells vul­ner­a­ble or re­sis­tant to dis­ease

Last week
Deals

As­traZeneca inks $247M deal with gen­er­a­tive AI shop Ab­sci to de­vel­op an­ti­body drug for can­cer

5 hours ago

Af­ter tar­get­ing strug­gling biotechs, Tang’s Con­cen­tra shifts gears with un­so­licit­ed bid for Lian­Bio

3 days ago

J&J ac­quires Cal­i­for­nia med­ical de­vice com­pa­ny for $400M

3 days ago

In FocusSee all

Ful­ly syn­thet­ic genome nears com­ple­tion in a step to­ward un­rav­el­ing ge­net­ic mys­ter­ies

4 weeks ago
R&D
Discovery

mR­NA’s next trick? Re­pro­gram­ming off-the-shelf cell ther­a­pies for can­cer and au­toim­mune dis­eases

4 weeks ago
Cell/Gene Tx

Ra­dio­phar­ma CD­MOs nav­i­gate sup­ply chain, raw ma­te­r­i­al chal­lenges as de­mand goes nu­clear

Last month
Manufacturing

Af­ter the ap­plause: New ef­fi­ca­cy ex­pec­ta­tions in urothe­lial can­cer af­ter Pad­cev-Keytru­da da­ta re­veal

Last month
R&D
Pharma

Endpoints Standouts

A con­ver­sa­tion with No­bel Prize win­ner Katal­in Karikó on re­jec­tion, fi­nal­ly be­ing rec­og­nized and her mR­NA work

2 months ago
People

Af­ter years of hype, the first AI-de­signed drugs fall short in the clin­ic

Last month
AI
In Focus

How No­vo Nordisk’s Ry­bel­sus went from pan­dem­ic washout to block­buster, and what’s next for oral weight loss

Last month
Pharma
Marketing

Most de­tailed hu­man brain map yet is ‘lay­ing the foun­da­tion for find­ing fu­ture cures’

Last month
R&D
In Focus

Peer review See all

Dec
1

Amy­lyx hires new CMO from Ul­tragenyx; Eliot Forster is back as a CEO af­ter F-star sale

Nov
17

De­sign Ther­a­peu­tics hints at ‘strate­gic re­align­ment,’ re­places CEO; Karyopharm co-founder leads AT­P's Nereid

Nov
10

Cen­tu­ry Ther­a­peu­tics nabs Bris­tol My­ers alum as CEO; En­her­tu star Dai­ichi Sankyo makes changes in Eu­rope

Nov
3

CNS biotech Rap­port snags a CFO vet­er­an from Karuna; Bris­tol My­ers’ new CEO to chair the board next year

Oct
27

Flag­ship's Mon­tai Health hires first CMO; Fi­nance leader to re­tire at J&J part­ner Xen­cor

Pharma channel feed

6 hours ago

FDA ap­proves Lil­ly’s BTK in­hibitor Jaypir­ca for two more blood can­cers

The FDA grant­ed ac­cel­er­at­ed ap­proval to Eli Lil­ly's Jaypir­ca for cer­tain pa­tients with chron­ic lym­pho­cyt­ic leukemia or small lym­pho­cyt­ic lym­phoma, the In­di­anapo­lis-based phar­ma com­pa­ny ...

READ MORE

Sam­sung Bioepis strikes deal for Ste­lara biosim­i­lar, but launch like­ly won't come in time for an IRA ex­emp­tion

2 days ago
FDA+

EMA sends more ques­tions to GLP-1 mak­ers over pos­si­ble risk of sui­cide, self-harm

2 days ago
latest in Pharma

As­traZeneca halts two PhI­II hy­per­kalemia stud­ies in­tend­ed to spot­light Lokel­ma’s clin­i­cal val­ue

3 days ago

No­vo Nordisk ramps up le­gal case against com­pound­ing phar­ma­cies sell­ing 'mis­brand­ed' semaglu­tide

3 days ago
Law

FDA ships Form 483 to gener­ic drug gi­ant Dr. Red­dy’s due to equip­ment is­sues, oth­er ob­ser­va­tions

3 days ago
FDA+
Manufacturing

GSK is win­ning 70% of the RSV mar­ket, while Pfiz­er's launch has left it ‘dis­ap­point­ed’ so far

3 days ago

Up­dat­ed: Ab­b­Vie to ac­quire Im­muno­Gen for $10B in ban­ner year for AD­Cs

4 days ago
Deals
see latest stories

Marketing channel feed

2 days ago

Pfiz­er, Idor­sia and Ab­b­Vie drug brands lead the way in phar­ma dig­i­tal mar­ket­ing — study

What do pop­u­lar Stan­ley in­su­lat­ed cups have in com­mon with two phar­ma mi­graine brands? They’re all trans­for­ma­tion­al dig­i­tal brands, ac­cord­ing to new re­search out this week.

READ MORE

No­var­tis taps ‘So­pra­nos’ ac­tress for new mul­ti­ple scle­ro­sis Kes­imp­ta cam­paign

2 days ago
Pharma

Ot­su­ka am­pli­fies re­search-based men­tal health pro­gram, adds first dig­i­tal ac­cess

3 days ago
Pharma
latest in Marketing

Drug prices in TV ads again? Sen­a­tors take an­oth­er swing with ex­pe­dit­ed bill

3 days ago
Pharma

Mar­ket­ingRx roundup: Pfiz­er adds hol­i­day twist to Covid boost­er ef­fort; No­vavax signs up for sports

5 days ago
Pharma

Take­da aligns with lead­ing rare dis­ease group for calls to ac­tion around health eq­ui­ty di­ag­noses

6 days ago
Pharma

Who cares about phar­ma ESG ef­forts? Pa­tients and pa­tient groups do — and they want more, sur­vey finds

6 days ago
Pharma

Mar­ius aims to shake up typ­i­cal think­ing about testos­terone in new cam­paign

6 days ago
Pharma
see latest stories

FDA+ channel feed

2 days ago

Apel­lis' eye dis­ease drug gets safe­ty la­bel up­date for rare in­flam­ma­tion side ef­fect

The FDA and Apel­lis Phar­ma­ceu­ti­cals have up­dat­ed the la­bel for Syfovre — an in­jec­tion for late-stage wet age-re­lat­ed mac­u­lar de­gen­er­a­tion — to ad­dress the po­ten­tial risk of eye ...

READ MORE

More com­pa­nies need to set di­ver­si­ty en­roll­ment goals in can­cer tri­als, FDA says

3 days ago

Clin­i­cians say ben­e­fits of CAR-T con­tin­ue to out­weigh risk of T-cell ma­lig­nan­cies

4 days ago
Pharma
Cell/Gene Tx
latest in FDA+

Sen­ate Fi­nance Com­mit­tee to re­view fed­er­al poli­cies on drug short­ages

4 days ago
Law

In­tas Phar­ma­ceu­ti­cal­s' In­di­an fa­cil­i­ty hit with FDA warn­ing let­ter, placed on im­port alert

4 days ago
Manufacturing

FDA to make de­ci­sion about Karuna's schiz­o­phre­nia drug by next Sep­tem­ber

5 days ago
R&D

FDA opens re­view of CAR-T safe­ty af­ter iden­ti­fy­ing 19 cas­es of post-treat­ment blood can­cer

5 days ago
Pharma
Cell/Gene Tx

Aldeyra's dry eye drug gets a re­jec­tion from the FDA

6 days ago
see latest stories

Manufacturing channel feed

4 days ago

2024 VC fore­cast: Clin­i­cal-stage CD­MOs like­ly to have uptick in de­mand but spe­cial­iza­tion crit­i­cal

Clin­i­cal-stage CD­MOs should ex­pect a rise in de­mand in 2024 as fund­ing for ear­ly-stage bio­phar­ma sta­bi­lizes and biotechs may shed their in-house man­u­fac­tur­ing to save cash, ac­cord­ing to ...

READ MORE

Charles Riv­er works on rare dis­ease gene ther­a­py; Emer­gent gets $75M for an­thrax vac­cine; Eu­roAPI hires new COO 

4 days ago

Cell man­u­fac­tur­ing com­pa­ny rais­es $19M Se­ries A to in­crease ca­pac­i­ty, staff num­bers 

4 days ago
Financing
latest in Manufacturing

Am­gen teams up with Ama­zon on AI plat­form to en­hance new Ohio man­u­fac­tur­ing site

5 days ago
AI

Big Phar­ma unites to help boost re­new­able en­er­gy for sup­ply chains in Chi­na and In­dia

5 days ago

RoslinCT to com­mer­cial­ly man­u­fac­ture CRISPR-edit­ed ther­a­py Cas­gevy af­ter col­lab ex­ten­sion with Ver­tex, CRISPR

6 days ago
Cell/Gene Tx

US gov­ern­ment turns to more do­mes­tic phar­ma man­u­fac­tur­ing to im­prove sup­ply chain re­silience 

6 days ago
Pharma

No­vo Nordisk in­vests $2.4B in French fa­cil­i­ty to ad­dress boom­ing GLP-1 de­mand

Last week
see latest stories
A service from the Financial Times